KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Non-Current Liabilities (2016 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $19.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 6.87% year-over-year to $19.4 billion, compared with a TTM value of $19.4 billion through Dec 2025, down 6.87%, and an annual FY2025 reading of $19.4 billion, down 6.87% over the prior year.
  • Total Non-Current Liabilities was $19.4 billion for Q4 2025 at Teva Pharmaceutical Industries, down from $21.1 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $25.9 billion in Q1 2021 and bottomed at -$10.9 billion in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $21.4 billion, with a median of $23.3 billion recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities tumbled 146.38% in 2024, then surged 296.32% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $25.4 billion in 2021, then dropped by 6.1% to $23.8 billion in 2022, then fell by 3.1% to $23.1 billion in 2023, then decreased by 9.94% to $20.8 billion in 2024, then fell by 6.87% to $19.4 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for TEVA at $19.4 billion in Q4 2025, $21.1 billion in Q3 2025, and $21.4 billion in Q2 2025.